ACS Chem Biol. 2019 Dec 20;14(12):2576-2584. doi: 10.1021/acschembio.9b00429. Epub 2019 Nov 6.
ADP-ribosyltransferases transfer ADP-ribose from β-NAD to acceptors; ADP-ribosylated acceptors are cleaved by ADP-ribosyl-acceptor hydrolases (ARHs) and proteins containing ADP-ribose-binding modules termed macrodomains. On the basis of the ADP-ribosyl-arginine hydrolase 1 (ARH1) stereospecific hydrolysis of α-ADP-ribosyl-arginine and the hypothesis that α-NAD is generated as a side product of β-NAD/ NADH metabolism, we proposed that α-NAD was a substrate of ARHs and macrodomain proteins. Here, we report that ARH1, ARH3, and macrodomain proteins (i.e., MacroD1, MacroD2, C6orf130 (TARG1), Af1521, hydrolyzed α-NAD but not β-NAD. ARH3 had the highest α-NADase specific activity. The ARH and macrodomain protein families, in stereospecific reactions, cleave ADP-ribose linkages to N- or O- containing functional groups; anomerization of α- to β-forms (e.g., α-ADP-ribosyl-arginine to β-ADP-ribose- (arginine) protein) may explain partial hydrolysis of ADP-ribosylated acceptors with an increase in content of ADP-ribosylated substrates. Af1521 and ARH3 crystal structures with bound ADP-ribose revealed similar ADP-ribose-binding pockets with the catalytic residues of the ARH and macrodomain protein families in the N-terminal helix and loop. Although the biological roles of the ARHs and macrodomain proteins differ, they share enzymatic and structural properties that may regulate metabolites such as α-NAD.
ADP-核糖基转移酶将 ADP-核糖从 β-NAD 转移到受体上;ADP-核糖基受体被 ADP-核糖基受体水解酶(ARHs)和含有 ADP-核糖结合模块的蛋白质(称为宏结构域)切割。基于 ADP-核糖基精氨酸水解酶 1(ARH1)对 α-ADP-核糖基精氨酸的立体特异性水解,以及假设 α-NAD 是 β-NAD/NADH 代谢的副产物生成的,我们假设 α-NAD 是 ARHs 和宏结构域蛋白的底物。在这里,我们报告 ARH1、ARH3 和宏结构域蛋白(即 MacroD1、MacroD2、C6orf130(TARG1)、Af1521)水解 α-NAD,但不水解 β-NAD。ARH3 具有最高的 α-NADase 比活性。在立体特异性反应中,ARH 和宏结构域蛋白家族切割 ADP-核糖键连接到含有 N 或 O 的功能基团;α-异构体到 β-异构体的互变(例如,α-ADP-核糖基精氨酸到 β-ADP-核糖基(精氨酸)蛋白)可能解释了 ADP-核糖基化受体的部分水解,同时 ADP-核糖基化底物的含量增加。与结合的 ADP-核糖的 Af1521 和 ARH3 晶体结构揭示了具有相似的 ADP-核糖结合口袋,具有 ARH 和宏结构域蛋白家族的催化残基在 N 端螺旋和环中。尽管 ARHs 和宏结构域蛋白的生物学作用不同,但它们具有酶和结构特性,可能调节代谢物如 α-NAD。